TLDR: dHealth Intelligence, a Swiss healthcare AI startup, has launched a new AI agent designed to consolidate fragmented medical data and provide private AI medical consultations. Available as a free desktop download, the platform transforms various health records into a unified narrative, ensuring patient privacy through a ‘personal cryptographic fortress.’ Mobile versions are expected in Q1 2026. The company, founded in 2017, boasts partnerships with major pharmaceutical firms like Roche, Novartis, and Eli Lilly.
ZURICH, SWITZERLAND – September 29, 2025 – dHealth Intelligence, a pioneering healthcare AI startup based in Switzerland, has officially unveiled a revolutionary AI agent aimed at transforming personal healthcare management. The new platform, available immediately as a free desktop download, addresses critical challenges within the healthcare sector: the pervasive fragmentation of medical data and the scarcity of truly private AI-driven health consultations.
The AI agent’s core functionality lies in its ability to consolidate disparate medical information—ranging from hospital records and wearable fitness data to handwritten doctor’s notes—into a cohesive, unified health narrative. This hands-free approach allows users to interpret every data point, converting raw inputs into standardized medical formats through simple commands, such as voicing a symptom, uploading medical imaging, or syncing a fitness device.
Patient privacy and data security are central to dHealth Intelligence’s design. The platform employs a robust security architecture, creating what the company describes as a ‘personal cryptographic fortress‘ for each user’s medical information. This ensures that sensitive health data remains under individual control, while still facilitating authorized sharing with healthcare providers and researchers when explicitly permitted by the user. The system validates credentials, translates complex permissions into plain language for user approval, and maintains an immutable record of consent decisions.
Founded in 2017, dHealth Intelligence has a proven track record, having established partnerships with global pharmaceutical giants including Roche, Novartis, and Eli Lilly. The company has deployed solutions across continents, from vaccine tracking in West Africa to rare disease research platforms with Roche, underscoring its commitment to delivering cutting-edge technology.
Also Read:
- Carta Healthcare Recognized as Finalist in 2025 A.I. Awards for Pioneering AI Use in Healthcare
- Cancer AI Alliance Launches Groundbreaking Federated Learning Platform to Accelerate Research and Protect Patient Privacy
Looking ahead, dHealth Intelligence plans to release mobile versions of the AI agent in Q1 2026. The company is also developing ‘Healthcare Outcome Markets,’ an innovative participatory ecosystem designed to transform medical research. This initiative will allow individuals to stake predictions on treatment outcomes, providing pharmaceutical companies with crucial risk management tools for expensive trials and offering the public unprecedented access to a healthcare prediction market. The launch of the desktop agent marks a significant milestone, positioning dHealth Intelligence at the forefront of privacy-first healthcare technology.
